Aequus Pharmaceuticals Inc.
AQS.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -41.61% | -81.98% | 38.63% | 55.68% | 261.57% |
| Total Receivables | -44.86% | 228.09% | 11.25% | -53.49% | 537.04% |
| Inventory | -37.82% | 106.64% | -38.95% | -31.25% | 460.91% |
| Prepaid Expenses | 34.01% | -27.69% | 11.36% | -12.43% | 56.82% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.22% | -0.91% | -2.65% | 2.41% | -2.06% |
| Total Current Assets | -26.89% | -11.44% | 6.27% | -8.41% | 187.70% |
|
|
|||||
| Total Current Assets | -26.89% | -11.44% | 6.27% | -8.41% | 187.70% |
| Net Property, Plant & Equipment | -4.43% | -6.36% | -7.45% | -2.63% | -6.85% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -13.88% | -8.58% | -1.92% | -5.05% | 29.59% |
|
|
|||||
| Total Accounts Payable | 31.20% | 1.60% | 20.52% | -43.33% | 103.27% |
| Total Accrued Expenses | 12.18% | 171.16% | -32.60% | -75.42% | 70.12% |
| Short-term Debt | 8.09% | 9.81% | 11.71% | 32.83% | 26.88% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.43% | 2.02% | 0.72% | 7.20% | 3.32% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 9.39% | 10.00% | 11.57% | 18.50% | 33.54% |
|
|
|||||
| Total Current Liabilities | 9.39% | 10.00% | 11.57% | 18.50% | 33.54% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 8.09% | 9.81% | 11.71% | 32.83% | 26.88% |
| Capital Leases | -4.77% | -6.58% | -7.51% | -2.36% | -6.35% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.28% | 8.48% | 9.50% | 15.81% | 26.61% |
|
|
|||||
| Common Stock & APIC | 1.31% | -1.06% | -2.47% | 2.43% | -2.11% |
| Retained Earnings | -3.14% | -0.97% | 0.50% | -4.73% | -0.41% |
| Treasury Stock & Other | 1.49% | -0.67% | -2.30% | 2.64% | -1.87% |
| Total Common Equity | -12.26% | -12.25% | -12.39% | -22.62% | -25.66% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -12.26% | -12.25% | -12.39% | -22.62% | -25.66% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.26% | -12.25% | -12.39% | -22.62% | -25.66% |
|
|
|||||
